review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1146/ANNUREV.IY.09.040191.002031 |
P698 | PubMed publication ID | 1910682 |
P2093 | author name string | Wang CR | |
Fischer Lindahl K | |||
Hermel E | |||
Loveland BE | |||
P304 | page(s) | 351-372 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Annual Review of Immunology | Q567362 |
P1476 | title | Maternally transmitted antigen of mice: a model transplantation antigen | |
P478 | volume | 9 |
Q30468888 | A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. |
Q40434714 | A Major Component of Radiation Action: Interference with Intracellular Control of Differentiation |
Q34211127 | A mitochondrial etiology of Alzheimer and Parkinson disease |
Q36362818 | A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides |
Q71596225 | A physical map of the Q region of B1O.P. |
Q41603473 | Acquired immunity to an intracellular pathogen: immunologic recognition of L. monocytogenes-infected cells |
Q42637310 | Allelic repertoire of the human MHC class I MICA gene |
Q36314994 | Applications of tissue engineering in the genitourinary tract |
Q37123348 | Assembly and intracellular transport of major histocompatibility complex molecules |
Q38312426 | Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera. |
Q35533657 | Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes |
Q41452265 | Class Ib MHC products in host immunity against Listeria monocytogenes |
Q41139471 | Do we need a pepton hypothesis? |
Q35654346 | Does the mitochondrial DNA play a role in the pathogenesis of diabetes? |
Q42804122 | Epitope selection in major histocompatibility complex class I-mediated pathway is affected by the intracellular localization of an antigen |
Q24799692 | Estrogen, mitochondria, and growth of cancer and non-cancer cells |
Q35085506 | Expression of nonclassical MHC class Ib genes: comparison of regulatory elements |
Q36360947 | Generation of T cells with lytic specificity for atypical antigens. I. A mitochondrial antigen in the rat. |
Q34524710 | Generation of histocompatible tissues using nuclear transplantation. |
Q33343554 | H-2M3 encodes the MHC Class I molecule presenting the maternally transmitted antigen of the mouse |
Q28511739 | HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen |
Q28585027 | Ham-2 corrects the class I antigen-processing defect in RMA-S cells |
Q36498790 | Human embryonic stem cells: preclinical perspectives |
Q41561713 | Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy |
Q71655418 | Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen |
Q36813790 | Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. |
Q31127213 | Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT. |
Q36482579 | Intracellular peptide transporters in human--compartmentalization of the "peptidome". |
Q40612811 | MHC ligands and peptide motifs: first listing |
Q36525599 | Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells |
Q37958346 | Minor histocompatibility antigens as risk factor for poor prognosis in kidney transplantation |
Q26781103 | Mitochondrial DNA variation in human radiation and disease |
Q55922467 | Mitochondrial Proteins at Unexpected Cellular Locations: Export of Proteins from Mitochondria from an Evolutionary Perspective |
Q33632943 | Mitochondrial-matrix proteins at unexpected locations: are they exported? |
Q35675786 | Mouse chromosome 17. |
Q24561711 | Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex |
Q42612908 | Organization and structure of the H-2M4-M8 class I genes in the mouse major histocompatibility complex |
Q41989207 | Positive selection of MHC class Ib-restricted CD8(+) T cells on hematopoietic cells |
Q41250653 | Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements |
Q33536516 | Responses of CD8(+) T cells to intracellular bacteria |
Q36230457 | Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic origin |
Q35584782 | Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex |
Q46984111 | Switching of the homooligomeric ATP-binding cassette transport complex MDL1 from post-translational mitochondrial import to endoplasmic reticulum insertion |
Q28258860 | TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide |
Q36362894 | TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells |
Q40373273 | The CD1 family: a third lineage of antigen-presenting molecules |
Q41088682 | The enigmatic specificity of gamma delta T cells |
Q28239867 | The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 |
Q34469793 | The involvement of class Ib molecules in the host response to infection with Salmonella and its relevance to autoimmunity |
Q36375172 | The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides |
Q41278544 | The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association |
Q41561945 | The role of natural killer cells in allograft responses to MHC antigens in the rat. |
Q35749925 | Therapeutic cloning and tissue engineering |
Q35781204 | Therapeutic cloning applications for organ transplantation |
Q35661050 | Tissue engineering for the replacement of organ function in the genitourinary system |
Q36194058 | Tissue engineering, stem cells and cloning: current concepts and changing trends |
Q35585774 | Tissue engineering, stem cells, and cloning for the regeneration of urologic organs |
Q24809660 | Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy |
Q35909647 | Toward a genetic analysis of tumor rejection antigens. |
Q72798659 | Transcription of rat mitochondrial NADH-dehydrogenase subunits. Presence of antisense and precursor RNA species |
Q74381909 | Transplanting cloned cells into therapeutic promise |
Search more.